Teva Pharmaceutical Industries Ltd (TEVA)
12.86
+0.08
(+0.59%)
USD |
NYSE |
Apr 19, 16:00
12.85
0.00 (0.00%)
After-Hours: 17:13
Teva Pharmaceutical Industries Cash from Operations (TTM): 1.368B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.368B |
| September 30, 2023 | 1.157B |
| June 30, 2023 | 1.695B |
| March 31, 2023 | 1.494B |
| December 31, 2022 | 1.59B |
| September 30, 2022 | 1.073B |
| June 30, 2022 | 1.059B |
| March 31, 2022 | 1.154B |
| December 31, 2021 | 798.00M |
| September 30, 2021 | 673.00M |
| June 30, 2021 | 451.00M |
| March 31, 2021 | 506.00M |
| December 31, 2020 | 1.216B |
| September 30, 2020 | 1.423B |
| June 30, 2020 | 1.441B |
| March 31, 2020 | 941.00M |
| December 31, 2019 | 748.00M |
| September 30, 2019 | 577.00M |
| June 30, 2019 | 673.00M |
| March 31, 2019 | 1.062B |
| December 31, 2018 | 2.446B |
| September 30, 2018 | 2.938B |
| June 30, 2018 | 3.312B |
| March 31, 2018 | 3.585B |
| December 31, 2017 | 2.225B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.456B |
| June 30, 2017 | 2.122B |
| March 31, 2017 | 2.65B |
| December 31, 2016 | 3.89B |
| September 30, 2016 | 5.415B |
| June 30, 2016 | 5.047B |
| March 31, 2016 | 5.564B |
| December 31, 2015 | 5.542B |
| September 30, 2015 | 5.679B |
| June 30, 2015 | 6.01B |
| March 31, 2015 | 5.583B |
| December 31, 2014 | 5.127B |
| September 30, 2014 | 4.191B |
| June 30, 2014 | 3.211B |
| March 31, 2014 | 3.033B |
| December 31, 2013 | 3.237B |
| September 30, 2013 | 3.998B |
| June 30, 2013 | 4.602B |
| March 31, 2013 | 4.918B |
| December 31, 2012 | 4.572B |
| September 30, 2012 | 4.423B |
| June 30, 2012 | 3.857B |
| March 31, 2012 | 3.99B |
| December 31, 2011 | 4.134B |
| September 30, 2011 | 3.808B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
451.00M
Minimum
Jun 2021
1.695B
Maximum
Jun 2023
1.055B
Average
1.073B
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Viatris Inc | 2.800B |
| Johnson & Johnson | 22.79B |
| GSK PLC | 8.422B |
| Novartis AG | 14.46B |
| Sanofi SA | -- |